The system of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) may play a key role in atherogenesis of chronic kidney disease (CKD) patients by its impact on matrix accumulation.

Obesity is associated with increased morbidity and mortality from atherosclerotic disease. Nontraditional cardiovascular risk factors such as C-reactive protein (CRP) and interleukin-6 (IL-6) are ...

Matrix metalloproteinase 9 (MMP9) levels in serum and cerebrospinal fluid (CSF) are known to be elevated in patients with multiple sclerosis; these patients also have lower than normal levels of ...